About Vinkem
Vinkem is an Industrial Goods & Manufacturing company. Manufacturing of oncology drugs, API, and related services in India. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. The company has 1 employees. Its Indian entity Vinkem Labs Limited reported revenue of ₹21 Lakh. Vinkem offers products and services including Oncology Drugs and API Manufacturing. Its focus areas include Manufacturing, Contract Manufacturing, API Production and Pharmaceuticals.
Company details
Vinkem is recognized for its oncology products and pharmaceutical manufacturing, where state-of-the-art facilities are utilized to produce high-quality API and injectables. Innovation in RD is emphasized through DSIR-approved setups, and customer relationships are maintained via effective partnerships. Advanced equipment and professional ethics ensure trusted quality, while complex molecules are developed with a commitment to efficiency and safety. Locations in Tamil Nadu and Andhra Pradesh support comprehensive operations, fostering a focus on patient safety and reliable drug production.
- Employees 1
- SectorsIndustrial Goods & ManufacturingHealthcare
- Email••••••••
- Website vinkem.com
- Legal Name Vinkem Labs Ltd
- Date of Incorporation 21 Dec, 1994
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹21 Lakh
FY 2017 · +44% YoY
- Indian entity net loss-₹19.9 Lakh
FY 2017 · -95% margin
- Indian entity EBITDA₹1.6 Lakh
FY 2017 · 8% margin
- Employee Count1
Associated legal entities of Vinkem
Vinkem operates through Vinkem Labs Limited (under liquidation). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2017) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vinkem Labs Limited CIN U24231TN1994PLC029622 | Under Liquidation | 21 Dec 1994 | Chennai, Tamil Nadu | ₹0.2 Cr | 6 | View details |
Products & Services of Vinkem
Vinkem offers a comprehensive portfolio of products and services, including Oncology Drugs and API Manufacturing.
Oncology drugs are manufactured for treatment purposes using innovative technology and advanced facilities.
Active Pharmaceutical Ingredients are produced through contract manufacturing processes in dedicated facilities.
Board of directors of Vinkem Labs Limited (Vinkem)
Vinkem Labs Limited is the primary company behind Vinkem. The board of Vinkem Labs Limited currently have 6 directors; the longest-serving is Munusamy Perumal, appointed in 1994. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Munusamy Perumal DIN 01790521 | Managing Director | 21 Dec 1994 | 31 yrs 10 mo | Vinkem Labs Limited |
| Munusamy Palani DIN 02343476 | Director | 03 Mar 1995 | 31 yrs 8 mo | Vinkem Labs Limited |
| Perumal Mallika DIN 02343421 | Director | 23 Jan 2004 | 22 yrs 9 mo | Vinkem Labs Limited |
| Venkataraman Haridoss DIN 02343409 | Director | 23 Jan 2004 | 22 yrs 9 mo | Vinkem Labs Limited |
| Deepika Perumal DIN 08263106 | Additional Director | 23 Oct 2018 | 8 yrs | Vinkem Labs Limited |
| Rajendran Shanmugam DIN 00144568 | IRP/RP/Liquidator | 09 Dec 2024 | 1 yr 11 mo | Vinkem Labs Limited |
Financials of Vinkem
Figures of Vinkem Labs Limited, the primary company behind Vinkem, for FY 2017. Revenue was ₹21 Lakh (+44% year on year). Net loss was -₹19.9 Lakh (-95% margin). EBITDA was ₹1.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of -44% over three years.
- ₹21 LakhRevenue · FY 2017 · +44% YoY
- -₹19.9 LakhNet loss · -95% margin
- ₹1.6 LakhEBITDA · 8% margin
- ₹9.89 CrPaid-up capital
- -44%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Vinkem Labs Limited are on its company page.
Detailed financial statements for Vinkem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vinkem
Vinkem has 1 employees.
The primary company behind Vinkem, Vinkem Labs Limited, reported revenue of ₹21 Lakh for FY 2017, up 44% year on year.
Vinkem is recognized for its oncology products and pharmaceutical manufacturing, where state-of-the-art facilities are utilized to produce high-quality API and injectables. Innovation in RD is emphasized through DSIR-approved setups, and customer relationships are maintained via effective partnerships. Advanced equipment and professional ethics ensure trusted quality, while complex molecules are developed with a commitment to efficiency and safety. Locations in Tamil Nadu and Andhra Pradesh support comprehensive operations, fostering a focus on patient safety and reliable drug production.
Vinkem offers Oncology Drugs and API Manufacturing.
Vinkem operates through Vinkem Labs Limited.
The legal entities of Vinkem currently have 6 directors, including Perumal Mallika, Rajendran Shanmugam, Venkataraman Haridoss and others.